Shikha Mishra

Arvind Sagar, Senior Advisor, ProHance Data from 246,500+ users across 68 global enterprises highlights evolving trends in workforce flexibility, productivity, and application usage

Kishore Reddy, Co-founder & CTO, ProHance at SSON Houston 2025 Khiv Singh, SVP & Head – Americas, ProHance with Anand Baradwaj, Executive

ProHance at HIMSCON 2025 As healthcare leaders navigate tight margins and talent challenges, ProHance underscores how visibility and utilization can drive lasting productivity gains

Sriram Krishnan, Senior Director, ProHance at III Awards 2025 III Awards 2025

Fireside chat on “Data First Foundations: Building a Unified, Actionable Strategy.” ProHance Showcases Measurable Productivity Impact at SSOW 2026

ProHance CEO Ankur Dhingra at the ProHance Roundtable with IBPAP and Zinnov in Manila The ProHance Roundtable with IBPAP and Zinnov in Manila

ProHance COO Saurabh Sharma at Shared Services & GCC Week India 2026 Industry leaders discuss the role of systems, behavioural adoption and continuous improvement in driving sustainable productivity gains

The session on 'From AI Pilots to Enterprise ROI: How GCCs Baseline Work, Prove Impact, and Scale Adoption' led by Nitin Panicker, VP Enterprise Sales, India & Middle East, ProHance

ProHance has been recognised as a Major Contender and Star Performer in the Everest Group People Analytics Platforms PEAK Matrix® Assessment 2026

Histoplasmosis is an endemic mycosis in the central and eastern USA, Central and South America, parts of Asia, and Africa. It commonly presents as a pulmonary disease, but can involve multiple organ systems in immunocompromised individuals. In patients with HIV and low CD4 counts, usually <150 cells/μL, it can present with gastrointestinal symptoms, lymphadenopathy, and rarely as meningitis, or with mucocutaneous and adrenal involvement. Diagnostic modalities include direct visualisation of the fungus in tissue specimens, Histoplasma antigen detection in blood or urine, antibody detection, detection of DNA sequences by PCR, and culture of clinical specimens. Treatment is based on disease severity, with a long course of itraconazole and induction therapy with amphotericin B for moderate to severe infection. HIV patients with a CD4 count of <150 cells/μL in endemic areas with high disease incidence require prophylaxis. We report a case of a 35-year-old male with HIV infection who presented with diarrhoea and abdominal pain. Evaluation revealed retroperitoneal, mesenteric, supraclavicular lymphadenopathy, splenomegaly, ileitis, and colitis. Terminal ileum mucosa and supraclavicular lymph node biopsy specimens showed Histoplasma capsulatum on pathology with a positive tissue fungal culture. He was successfully treated with Itraconazole with symptomatic improvement.